Medication adherence of cardiovascular patients after COVID-19: 6-month follow-up

Medication adherence of cardiovascular patients after COVID-19: 6-month follow-up

Aim. To evaluate the relationship of various factors with adherence to therapy in cardiovascular patients after a coronavirus disease 2019 (COVID-19).Material and methods. The study included 284 patients (inpatients — 176, outpatients — 108) with cardiovascular diseases (hypertension, heart failure...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. R. Tyapaeva, E. A. Naumova, O. N. Semenova, Yu. V. Bulaeva, D. A. Tyapkina, A. A. Boroday
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2024-04-01
Series:	Российский кардиологический журнал
Subjects:	prospective study compliance treatment of cardiovascular disease cardiovascular diseases covid-19
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5605
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ADHERENCE TO LONG-TERM TREATMENT OF CARDIOVASCULAR DISEASE AND NON-COMPLIANCE WITH MEDICAL RECOMMENDATIONS: THE OPINION OF PATIENTS AND PHYSICIANS BY THE RESULTS OF FOCUSED INTERVIEW
by: O. N. Semenova, et al.
Published: (2015-09-01)

A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases
by: Yu. V. Bulaeva, et al.
Published: (2021-11-01)

THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS
by: S. A. Boytsov, et al.
Published: (2015-02-01)

RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES
by: E. V. Minakov, et al.
Published: (2016-01-01)

Remote outcomes in patients with cardiovascular diseases in outpatient practice: data from a 10-year follow-up within the RECVAZA registry
by: M. M. Luk'yanov, et al.
Published: (2025-02-01)

Technology-based methods in the improvement of therapy compliance among ambulatory cardiac patients: one-year follow-up data
by: F. T. Ageev, et al.
Published: (2012-08-01)

Clinical, laboratory and psychological aspects of moderate COVID-19 in cardiovascular patients one month after discharge from the hospital
by: A. R. Tyapaeva, et al.
Published: (2022-02-01)

OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. M. Loukianov, et al.
Published: (2015-09-01)

Compliance to cardiovascular treatment: clinicians and patients’ problem
by: G. V. Pogosova, et al.
Published: (2009-08-01)

Nutritional status and the risk of cardiovascular events. Results of a 6-year prospective follow-up of the ESSE-RF study cohort
by: N. S. Karamnova, et al.
Published: (2024-10-01)

DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES
by: E. V. Minakov, et al.
Published: (2016-01-01)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
by: N. В. Perepech, et al.
Published: (2018-05-01)

STUDY OF ADHERENCE TO DRUG THERAPY OF PATIENTS WITH CARDIOVASCULAR DISEASES IN DISTRICT HOSPITAL OF SMALL TOWN IN SARATOV REGION AND IN CARDIOLOGY DEPARTMENT OF UNIVERSITY CLINIC IN SARATOV
by: Yu. V. Bulaeva, et al.
Published: (2018-07-01)

Patients with cardiovascular diseases and NSAIDs use: real clinical practice
by: A. P. Rebrov, et al.
Published: (2021-01-01)

Hypertension as a death risk factor in men and women aged 20-59 years: a 34-year cohort prospective study
by: I. V. Dolgalev, et al.
Published: (2023-10-01)

Associations of liver fibrosis scores with cardiovascular disease incidence among adult rural Uyghurs in Xinjiang Uyghur Autonomous Region: a 6-year prospective follow-up study
by: Tingchao LIU, et al.
Published: (2025-02-01)

Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19
by: N. P. Kutishenko, et al.
Published: (2023-01-01)

ROSUVASTATIN - THE MOST POTENT STATIN IN CARDIOVASCULAR DISEASE PREVENTION
by: A. E. Semenova, et al.
Published: (2018-06-01)

COMPLIANCE TO LONG-TERM TREATMENT OF CARDIOLOGIC PATIENTS WITH MILD TO MODERATE DEPRESSION: INEFFECTIVENESS OF ANTIDEPRESSIVE THERAPY WITH PIRLINDOL IN RANDOMIZED STUDY
by: E. V. Strokova, et al.
Published: (2015-12-01)

Compliance as the major effectiveness determinant in preventive acetylsalicylic acid therapy
by: V. V. Rafalskiy, et al.
Published: (2011-04-01)

Efficacy of an intervention to increase therapeutic adherence in patients with secondary prevention for cardiovascular disease: a study protocol for a randomized controlled trial
by: Francisco Manuel Lidón-Muñoz, et al.
Published: (2025-01-01)

Young ambulatory patients with cardiovascular diseases: age and gender characteristics, comorbidity, medication and outcomes (according to RECVASA register)
by: E. Yu. Andreenko, et al.
Published: (2019-12-01)

Methods and validity indicators for measuring adherence to statins in secondary cardiovascular prevention: a systematic review
by: Adriana López-Pineda, et al.
Published: (2025-05-01)

Adherence to therapy and the risk of cardiovascular events in patients with heart failure: data from the outpatient registry
by: E. T. Guseinova, et al.
Published: (2022-11-01)

Cardiovascular risk calculation
by: James A. Ker
Published: (2014-12-01)

CARDIOVASCULAR HEALTH EVALUATION: FORMER FACTORS — NOVEL MODEL
by: A. E. Imaeva, et al.
Published: (2015-10-01)

Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19
by: A. A. Smirnov, et al.
Published: (2022-11-01)

Fruit and Vegetable Intake and Cardiovascular Disease in the UK Biobank: The Role of Confounding
by: Fiona MacLean, et al.
Published: (2024-08-01)

Challenges in managing adherence in patients with cardiovascular disease (review)
by: Yu. S. Ignatova, et al.
Published: (2025-01-01)

Smoking, smoking cessation, and cardiovascular and all-cause death risk (a 34-year cohort prospective study)
by: I. V. Dolgalev, et al.
Published: (2025-07-01)

Perception About Factors Affecting Patient Adherence With Cardiac Medicines: A Cross‐Sectional Study
by: Jesmin Sultana, et al.
Published: (2025-03-01)

THIRTY-TWO-YEAR DYNAMICS AND PROGNOSTIC SIGNIFICANCE OF BASELINE LEVELS OF SYSTEMIC PRESSURE IN TEENAGE BOYS
by: A. A. Aleksandrov, et al.
Published: (2017-10-01)

Anemia of chronic diseases: connection with cardiovascular pathology
by: S. A. Nedomolkina, et al.
Published: (2024-12-01)

The influence of anemia on cardiovascular disease course
by: A. V. Budnevsky, et al.
Published: (2016-02-01)

TREATMENT ADHERENCE AS AN ESSENTIAL ELEMENT OF CARDIOVASCULAR DISORDERS MANAGEMENT
by: D. V. Nebieridze, et al.
Published: (2017-12-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

Cardiovascular risk management system: prerequisites for developing, organization principles, target groups
by: E. V. Shlyakhto, et al.
Published: (2019-11-01)

Association of Family History of Cardiovascular Diseases in Boys Aged 12-13 Years with Structural and Functional Indicators of the Left Ventricle and Arterial Stiffness in the Age of 43-46 Years (Results of 32-Year Prospective Follow-up)
by: O. Yu. Isaykina, et al.
Published: (2020-01-01)

Association of Lipid Profile With Cardiovascular Diseases and All‐Cause Death: A 2‐Decade Follow‐Up of the Tehran Lipid and Glucose Study
by: Azra Ramezankhani, et al.
Published: (2025-08-01)

Strategies and methods for the correction of obesity and associated cardiovascular risk
by: T. Yu. Kuznetsova, et al.
Published: (2019-05-01)